News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Drug Development
Acrux Limited to Push on with Phase 3 Testosterone Trial
July 18, 2007
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Australian biotech Acrux Ltd will push ahead with phase III trials of its male testosterone replacement therapy, following the success of a recent US study.
Twitter
LinkedIn
Facebook
Email
Print
Clinical research
Phase 2
Australia
MORE ON THIS TOPIC
Manufacturing
Bora inks $122.5M takeover of MacroGenics facility to further US expansion
May 13, 2026
·
2 min read
·
Nick Paul Taylor
Obesity
Lilly maintains weight loss leadership as Foundayo, Zepbound keep pounds off after switching
May 13, 2026
·
2 min read
·
Tristan Manalac
Cardiovascular disease
BridgeBio stands up to Pfizer in ATTR-CM as late-stage data hint at better survival
May 12, 2026
·
2 min read
·
Tristan Manalac
Manufacturing
Lilly invests $4.5B in Indiana manufacturing, opens doors of 1st genetic medicine site
May 8, 2026
·
1 min read
·
Gabrielle Masson
